The current institutional shareholding score of NextCure Inc is 3.00, ranking 192 out of 387 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 48.41%, representing a quarter-over-quarter increase of 43.46%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 1.70% of shares outstanding, with 1.44% increase in holdings.